Novartis (NYSE: NVS) Q3 Earnings: Revenue Miss, EPS Beat, and Raised Outlook
Novartis (NYSE: NVS) reported strong earnings per share of $2.46, surpassing analyst estimates of $2.25, despite a slight miss on revenue at $14.52 billion against an expected $14.53 billion. The global drugmaker demonstrated robust sales growth, with revenue increasing from $13.91 billion a year…